MB-CART19.1
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for MB-CART19.1, covering 2017-10-25 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL) [Phase 1]